Skip to main navigation
  • Home
  • Engineered with Purpose
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
explore the
possibilities

Synlogic Therapeutics

Investor Relations

IR menu

  • Overview
  • News
    News Releases In the News
  • Events & Presentations
    Events Presentations
  • Publications
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Corporate Governance
    Governance Highlights Leadership Board of Directors Committee Composition Board Diversity Matrix
  • Financials
    SEC Filings Quarterly Results
  • Investor Resources
    FAQs Contact IR Email Alerts RSS Feeds

Event Details

  • Home
  • Engineered with Purpose
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds

Top-Line Phase 2 Data for PKU Program Webcast

Oct 18, 2022 at 8:30 AM EDT

To access the call by phone from the U.S. dial (800) 715-9871 (toll-free); for outside of the U.S. dial: (646) 307-1963.
Listen to webcast

Supporting Materials

View Presentation 2.3 MB

Investor Resources

  • Contact IR
  • Investor FAQs
  • RSS Feeds

Investor Email Alerts

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn
  • Youtube
  • Facebook
  • Instagram

Privacy and Terms

© 2023 Synlogic
Privacy Policy